查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1417727

人口篩檢市場報告：2030 年趨勢、預測和競爭分析

Population Screening Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

人群篩檢趨勢和預測

2024年至2030年，全球人口篩檢市場將以5.5%的複合年成長率成長。該市場的主要促進因素是醫生和患者中慢性病盛行率的增加以及對人口篩檢計劃領域的投資增加。全球人口篩檢市場的未來看起來充滿希望，大眾和高階市場都充滿機會。

人口篩檢市場洞察

Lucintel 預測，由於用於大規模篩檢更多疾病的新檢測套組的核准不斷增加，硬體設備在預測期內仍將是最大的細分市場。

由於進行全面人群篩檢的挑戰越來越大，大規模使用將繼續佔據該市場的很大一部分。

由於該地區政府採取了預防措施，北美在預測期內仍將是最大的地區。

常問問題

Q1.市場成長預測如何？

A1. 2024年至2030年，全球人口篩檢市場預期複合年成長率為5.5%。

Q2.影響市場成長的主要促進因素有哪些？

A2. 該市場的主要促進因素是醫生和患者中慢性病盛行率的增加以及對人口篩檢計畫部門的投資增加。

Q3.市場的主要細分市場有哪些？

A3. 大眾放映市場的未來性充滿希望，大眾和高階市場都有機遇。

Q4.市場上主要企業有哪些？

A4.人群篩檢主要企業如下。

  • Agilent Technologies
  • Thermo Fisher Scientific
  • QIAGEN
  • F. Hoffmann-La Roche
  • Quest Diagnostics

Q5.未來最大的細分市場是什麼？

A5.Lucintel 預計，由於用於大規模篩檢更多疾病的新檢測套組的核准不斷增加，硬體設備在預測期內仍將是其最大的細分市場。

Q6. 未來五年預計哪個地區將成為最大的市場？

A6. 在預測期內，由於政府的預防措施，北美仍將是最大的地區。

Q7. 可以客製化報告嗎？

A7. 是的，Lucintel 提供 10% 的客製化服務，無需額外費用。

目錄

第1章執行摘要

第2章全球人群篩檢市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球人口篩檢市場趨勢（2018-2023）與預測（2024-2030）
  • 按產品分類的全球人口篩檢市場
    • 硬體設備
    • 測試/研究
    • 分析/解釋
  • 按性別分類的全球人口篩檢市場
    • 男性
    • 女士
  • 按類型分類的全球人口篩檢市場
    • 大眾市場
    • 優質的
  • 按業務分類的全球人口篩檢市場
    • 醫院
    • 調查機構
    • 診斷實驗室

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球人口篩檢市場（按地區）
  • 北美人口篩檢市場
  • 歐洲人口篩檢市場
  • 亞太地區人口篩檢市場
  • 其他地區人口篩檢市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按產品分類的全球人口篩檢市場成長機會
    • 按性別分類的全球人口篩檢市場成長機會
    • 按類型分類的全球人口篩檢市場成長機會
    • 全球人口篩檢市場成長機會（按業務）
    • 按地區分類的全球人口篩檢市場成長機會
  • 全球人口篩檢市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球人口篩檢市場的能力
    • 全球人口篩檢市場的合併、收購和合資
    • 認證和許可

第7章主要企業概況

  • Agilent Technologies
  • Thermo Fisher Scientific
  • QIAGEN
  • F. Hoffmann-La Roche
  • Quest Diagnostics
簡介目錄

Population Screening Trends and Forecast

The future of the global population screening market looks promising with opportunities in the mass and premium markets. The global population screening market grow with a CAGR of 5.5% from 2024 to 2030. The major drivers for this market are growing prevalence of chronic diseases among physicians and patients and rising investments in the field of population screening programs.

A more than 150-page report is developed to help in your business decisions.

Population Screening by Segment

The study includes a forecast for the global population screening by product, gender, type, business, and region.

Population Screening Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Hardware Equipment
  • Testing / Lab
  • Analytics / Interpretation

Population Screening Market by Gender [Shipment Analysis by Value from 2018 to 2030]:

  • Male
  • Female

Population Screening Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Mass
  • Premium

Population Screening Market by Business [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Research Institutes
  • Diagnostic Labs

Population Screening Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Population Screening Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies population screening companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the population screening companies profiled in this report include-

  • Agilent Technologies
  • Thermo Fisher Scientific
  • QIAGEN
  • F. Hoffmann-La Roche
  • Quest Diagnostics

Population Screening Market Insights

Lucintel forecasts that hardware equipment will remain the largest segment over the forecast period due to growing approval of novel test kits foe the population screening of more diseases.

Within this market, mass will remain the larger segment due to increasing challenges in conducting comprehensive population screening.

North America will remain the largest region over the forecast period due to precautionary actions implemented by government in the region.

Features of the Global Population Screening Market

Market Size Estimates: Population screening market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Population screening market size by various segments, such as by product, gender, type, business, and region in terms of value ($B).

Regional Analysis: Population screening market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, gender, types, businesses, and regions for the population screening market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the population screening market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for population screening market?

Answer: The global population screening market is expected to grow with a CAGR of 5.5% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the population screening market?

Answer: The major drivers for this market are growing prevalence of chronic diseases among physicians and patients and rising investments in the field of population screening programs.

Q3. What are the major segments for population screening market?

Answer: The future of the population screening market looks promising with opportunities in the mass and premium markets.

Q4. Who are the key population screening market companies?

Answer: Some of the key population screening companies are as follows.

  • Agilent Technologies
  • Thermo Fisher Scientific
  • QIAGEN
  • F. Hoffmann-La Roche
  • Quest Diagnostics

Q5. Which population screening market segment will be the largest in future?

Answer: Lucintel forecasts that hardware equipment will remain the largest segment over the forecast period due to growing approval of novel test kits foe the population screening of more diseases.

Q6. In population screening market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to precautionary actions implemented by government in the region.

Q.7 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the population screening market by product (hardware equipment, testing / lab, and analytics / interpretation), gender (male and female), type (mass and premium), business (hospitals, research institutes, and diagnostic labs), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Population Screening Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Population Screening Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Population Screening Market by Product
    • 3.3.1: Hardware Equipment
    • 3.3.2: Testing / Lab
    • 3.3.3: Analytics / Interpretation
  • 3.4: Global Population Screening Market by Gender
    • 3.4.1: Male
    • 3.4.2: Female
  • 3.5: Global Population Screening Market by Type
    • 3.5.1: Mass
    • 3.5.2: Premium
  • 3.6: Global Population Screening Market by Business
    • 3.6.1: Hospitals
    • 3.6.2: Research Institutes
    • 3.6.3: Diagnostic Labs

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Population Screening Market by Region
  • 4.2: North American Population Screening Market
    • 4.2.2: North American Population Screening Market by Type: Mass and Premium
  • 4.3: European Population Screening Market
    • 4.3.1: European Population Screening Market by Product: Hardware Equipment, Testing / Lab, and Analytics / Interpretation
    • 4.3.2: European Population Screening Market by Type: Mass and Premium
  • 4.4: APAC Population Screening Market
    • 4.4.1: APAC Population Screening Market by Product: Hardware Equipment, Testing / Lab, and Analytics / Interpretation
    • 4.4.2: APAC Population Screening Market by Type: Mass and Premium
  • 4.5: ROW Population Screening Market
    • 4.5.1: ROW Population Screening Market by Product: Hardware Equipment, Testing / Lab, and Analytics / Interpretation
    • 4.5.2: ROW Population Screening Market by Type: Mass and Premium

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Population Screening Market by Product
    • 6.1.2: Growth Opportunities for the Global Population Screening Market by Gender
    • 6.1.3: Growth Opportunities for the Global Population Screening Market by Type
    • 6.1.4: Growth Opportunities for the Global Population Screening Market by Business
    • 6.1.5: Growth Opportunities for the Global Population Screening Market by Region
  • 6.2: Emerging Trends in the Global Population Screening Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Population Screening Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Population Screening Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Agilent Technologies
  • 7.2: Thermo Fisher Scientific
  • 7.3: QIAGEN
  • 7.4: F. Hoffmann-La Roche
  • 7.5: Quest Diagnostics